Wanbangde Pharmaceutical Holdings Group Co., Ltd. Announcement on Abnormal Fluctuations in Stock Trading

MaticHoleFiller · 2026-04-01T23:11:57+00:00

Wanbangde Pharmaceutical announced that its stock price has fluctuated by more than 20% within 3 trading days. The company verified that there is no undisclosed material information, operations are normal, and the controlling shareholder is planning a share transfer agreement but does not affect control. Investors are reminded to pay attention to market risks.

MaticHoleFiller

2026-04-01 23:11:57

Abstract generation in progress

Stock code: 002082 Stock abbreviation: 万邦德 Announcement No.: 2026-015

Wanfangde Pharmaceutical Holding Group Co., Ltd.

Announcement on Abnormal Fluctuations in Stock Trading

The Company and all members of the Board of Directors warrant that the contents of this information disclosure are true, accurate, and complete, and contain no false records, misleading statements, or material omissions.

I. Overview of the Company’s Abnormal Stock Trading Fluctuations

Within three consecutive trading days (March 27, 2026, March 30, 2026, and March 31, 2026) the closing price increase exceeded 20% cumulatively for Wanfangde Pharmaceutical Holding Group Co., Ltd. (hereinafter referred to as the “Company”) stock. In accordance with the relevant provisions of the “Trading Rules of the Shenzhen Stock Exchange,” this situation falls under abnormal stock trading fluctuations.

II. Matters the Company Has Focus

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes